ZNF184 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.666400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.367800E-01
Normal-vs-Stage2
8.708300E-02
Normal-vs-Stage3
7.057700E-03
Normal-vs-Stage4
7.159800E-01
Stage1-vs-Stage2
7.194200E-01
Stage1-vs-Stage3
1.064440E-01
Stage1-vs-Stage4
4.537600E-01
Stage2-vs-Stage3
1.030570E-01
Stage2-vs-Stage4
1.719760E-01
Stage3-vs-Stage4
5.165800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.412500E-02
Normal-vs-AfricanAmerican
3.451200E-01
Normal-vs-Asian
9.644000E-02
Caucasian-vs-AfricanAmerican
5.377200E-01
Caucasian-vs-Asian
3.685400E-01
AfricanAmerican-vs-Asian
3.726600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.998300E-02
Normal-vs-Female
9.512200E-02
Male-vs-Female
6.935200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.676430E-01
Normal-vs-Age(41-60Yrs)
1.418980E-01
Normal-vs-Age(61-80Yrs)
8.311600E-02
Normal-vs-Age(81-100Yrs)
5.544100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.376800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.862400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.535400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.294200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.047800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.973600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.785900E-02
Normal-vs-Daily Drinker
6.186800E-04
Normal-vs-Weekly Drinker
6.381700E-02
Normal-vs-Occasional Drinker
2.669000E-01
Normal-vs-Social Drinker
1.133620E-01
Non Drinker-vs-Daily Drinker
5.639800E-02
Non Drinker-vs-Weekly Drinker
7.841000E-01
Non Drinker-vs-Occasional Drinker
1.503620E-01
Non Drinker-vs-Social Drinker
4.037800E-01
Daily Drinker-vs-Weekly Drinker
4.848400E-02
Daily Drinker-vs-Occasional Drinker
5.821700E-03
Daily Drinker-vs-Social Drinker
1.110320E-02
Weekly Drinker-vs-Occasional Drinker
3.373000E-01
Weekly Drinker-vs-Social Drinker
6.297000E-01
Occasional Drinker-vs-Social Drinker
6.013000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.024800E-01
Normal-vs-Grade 2
7.814000E-02
Normal-vs-Grade 3
6.681800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.550400E-02
Grade 1-vs-Grade 3
1.883750E-01
Grade 1-vs-Grade 4
2.024800E-01
Grade 2-vs-Grade 3
5.856800E-01
Grade 2-vs-Grade 4
7.814000E-02
Grade 3-vs-Grade 4
6.681800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.761000E-01
Normal-vs-NonDiabetic
3.787900E-02
Diabetic-vs-NonDiabetic
5.033600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.556800E-04
Normal-vs-NoPancreatitis
9.669800E-02
Pancreatitis-vs-NoPancreatitis
9.038500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.859600E-02
Normal-vs-N1
1.005560E-01
N0-vs-N1
7.034000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.945610E-01
Normal-vs-TP53-NonMutant
3.277200E-01
TP53-Mutant-vs-TP53-NonMutant
5.311200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
